当前位置： SCI文献检索 > BLOOD期刊下所有文献 > Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gamma.

Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gamma.

Abstract：

:Interferon (IFN) therapy has become widely used for the treatment of chronic myelogenous leukemia. Hematologic remissions can be induced in about 60% of patients. Moreover, in a small number of patients loss of the Philadelphia (Ph) chromosome and of the BCR-ABL rearrangement is observed. We have used genomic Southern blotting as well as a two-step polymerase chain reaction (PCR) method to score for BCR-ABL messenger RNA (mRNA) in patients with hematologic remission induced by treatment with IFN alpha-2b alone or in combination with IFN gamma. Concomitantly, cytogenetic analysis was performed. In 11 of 115 patients reported here, a complete loss of rearranged BCR fragments was observed in Southern blots of peripheral blood (PB) and/or bone marrow (BM) cell samples. Malignant marker bands disappeared first in the PB. In six patients, this genotype remained stable, whereas in five patients, low-intensity, rearranged bands reappeared despite continuation of treatment. The reappearance of the malignant marker was not accompanied by a clinical relapse. Ph-negative metaphases were observed in PB cells of four patients and in the PB and BM cells of two of these patients. In the samples of the other patients, residual Ph-positive cells were detected. By two-step PCR, residual BCR-ABL rearranged transcripts were found in samples of 10 patients.

journal_name

Blood

journal_title

Blood

authors

Opalka B,Wandl UB,Becher R,Kloke O,Nagel-Hiemke M,Moritz T,Beer U,Seeber S,Niederle N

subject

Has Abstract

pub_date

1991-11-01 00:00:00

pages

2188-93

issue

9

eissn

0006-4971

issn

1528-0020

journal_volume

78

pub_type

临床试验,杂志文章

相关文献

BLOOD文献大全
  • Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3.

    abstract：:MEIS1 is a three-amino acid loop extension class homeodomain-containing homeobox (HOX) cofactor that plays key roles in normal hematopoiesis and leukemogenesis. Expression of Meis1 is rate-limiting in MLL-associated leukemias and potently interacts with Hox and NUP98-HOX genes in leukemic transformation to promote sel...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2009-06-225573

    authors： Argiropoulos B,Yung E,Xiang P,Lo CY,Kuchenbauer F,Palmqvist L,Reindl C,Heuser M,Sekulovic S,Rosten P,Muranyi A,Goh SL,Featherstone M,Humphries RK

    更新日期：2010-05-20 00:00:00

  • Residual amounts of glycoproteins IIb and IIIa may be present in the platelets of most patients with Glanzmann's thrombasthenia.

    abstract：:Glanzmann's thrombasthenia is an inherited bleeding disorder characterized by abnormalities of platelet membrane glycoproteins (GP) IIb and IIIa. Most patients, usually designated as type I, have been reported to have undetectable levels of GP IIb and GP IIIa with the assay used. We have used polyclonal rabbit antibod...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Nurden AT,Didry D,Kieffer N,McEver RP

    更新日期：1985-04-01 00:00:00

  • Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients.

    abstract：:The survival of patients with aggressive non-Hodgkin lymphoma (NHL) is increasing, but the incidence of secondary cancer and late toxicity is poorly defined for those treated with cyclophosphamide-hydroxydaunomycin/doxorubicin-Oncovin-prednisone (CHOP)-like chemotherapy. From February 1984 to January 1998, 2837 patien...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2003-04-1124

    authors： André M,Mounier N,Leleu X,Sonet A,Brice P,Henry-Amar M,Tilly H,Coiffier B,Bosly A,Morel P,Haioun C,Gaulard P,Reyes F,Gisselbrecht C,Groupe D'Etude Des Lymphomes De L'Adulte.

    更新日期：2004-02-15 00:00:00

  • Expression cloning of cDNA encoding a novel human hematopoietic growth factor: human homologue of murine T-cell growth factor P40.

    abstract：:We used functional expression cloning in mammalian cells to identify a cDNA clone encoding a hematopoietic growth factor that is mitogenic for the factor-dependent human megakaryoblastic leukemic cell line, MO7E. Analysis of the sequence of this cDNA revealed striking similarity to that of a recently reported novel mu...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Yang YC,Ricciardi S,Ciarletta A,Calvetti J,Kelleher K,Clark SC

    更新日期：1989-11-01 00:00:00

  • The use of radiolabeled and fluorescein-labeled antiglobulins in assays to predict platelet transfusion outcome.

    abstract：:We used both radiolabeled and fluorescein-labeled antiglobulins in assays to detect antibodies against platelets in multiply transfused patients to determine the value of these tests in predicting the outcome of platelet transfusion in such patients. In 15 allosensitized patients, we studied 68 single-donor platelet t...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Ware R,Reisner EG,Rosse WF

    更新日期：1984-05-01 00:00:00

  • Autoimmune antibody in a hemorrhagic patient interacts with thrombin-activated factor XIII in a unique manner.

    abstract：:Without a prior history of hemorrhagic disease, a 62-year-old man suffered recurrent episodes of bleeding. Solubility of the patient's clot in 5 mol/L urea indicated a problem with fibrin stabilization. The transamidase activity potential of factor XIII, measured by the incorporation of radioactive putrescine into N,N...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Lorand L,Velasco PT,Murthy SN,Lefebvre P,Green D

    更新日期：1999-02-01 00:00:00

  • SLFN11 promotes stalled fork degradation that underlies the phenotype in Fanconi anemia cells.

    abstract：:Fanconi anemia (FA) is a hereditary disorder caused by mutations in any 1 of 22 FA genes. The disease is characterized by hypersensitivity to interstrand crosslink (ICL) inducers such as mitomycin C (MMC). In addition to promoting ICL repair, FA proteins such as RAD51, BRCA2, or FANCD2 protect stalled replication fork...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood.2019003782

    authors： Okamoto Y,Abe M,Mu A,Tempaku Y,Rogers CB,Mochizuki AL,Katsuki Y,Kanemaki MT,Takaori-Kondo A,Sobeck AT,Bielinsky AK,Takata M

    更新日期：2020-07-31 00:00:00

  • Corticosteroid modulation of interleukin-1 hematopoietic effects and toxicity in a murine system.

    abstract：:Interleukin-1 (IL-1) has been shown to ameliorate the hematopoietic toxicities of antitumor chemotherapeutic agents in both mice and humans. However, IL-1 toxicity in humans is considerable and is similar to the systemic inflammatory toxicities induced by IL-3, IL-6, and other cytokines with pleiotropic biologic activ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Rinehart J,Delamater EW,Keville L,Measel J

    更新日期：1994-09-01 00:00:00

  • Critical role of class IA PI3K for c-Rel expression in B lymphocytes.

    abstract：:The fact that the Xid mutation of Btk impairs the ability of pleckstrin homology domain of Btk to bind phosphatidylinositol-(3,4,5)-trisphosphate, a product of class IA phosphoinositide-3 kinases (PI3Ks), has been considered strong evidence for the hypothesis that Btk functions downstream of PI3Ks. We demonstrate here...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2008-06-163725

    authors： Matsuda S,Mikami Y,Ohtani M,Fujiwara M,Hirata Y,Minowa A,Terauchi Y,Kadowaki T,Koyasu S

    更新日期：2009-01-29 00:00:00

  • Production and nucleotide sequence of an inhibitory human IgM autoantibody directed against platelet glycoprotein Ia/IIa.

    abstract：:Human B-cell lines were derived by limiting dilutions of Epstein-Barr virus (EBV) transformed peripheral B cells from a patient with an autoantibody against glycoprotein (GP)Ia/IIa, and manifesting defective collagen-induced platelet aggregation and a bleeding problem. Antibody-producing clones were selected for their...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Deckmyn H,Zhang J,Van Houtte E,Vermylen J

    更新日期：1994-09-15 00:00:00

  • The C-class chemokine lymphotactin costimulates the apoptosis of human CD4(+) T cells.

    abstract：:Clonal expansion of activated T cells is controlled by homeostatic mechanisms leading to cell death of a large proportion of the cells. The CD3/TcR pathway induces cell death, mostly when triggered in the absence of costimulatory signal. The unique T cell-specific chemokine of the C class, lymphotactin (Lptn), has rec...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood.v97.8.2205

    authors： Cerdan C,Devilard E,Xerri L,Olive D

    更新日期：2001-04-15 00:00:00

  • Five years of experience with hydroxyurea in children and young adults with sickle cell disease.

    abstract：:The short-term beneficial effect of hydroxyurea (HU) in sickle cell disease (SCD) has been proven by randomized studies in children and adults. The Belgian registry of HU-treated SCD patients was created to evaluate its long-term efficacy and toxicity. The median follow-up of the 93 patients registered is 3.5 years; c...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood.v97.11.3628

    authors： Ferster A,Tahriri P,Vermylen C,Sturbois G,Corazza F,Fondu P,Devalck C,Dresse MF,Feremans W,Hunninck K,Toppet M,Philippet P,Van Geet C,Sariban E

    更新日期：2001-06-01 00:00:00

  • Sirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphoma.

    abstract：:Understanding the molecular pathogenesis of lymphoma has led to paradigm-changing treatment opportunities. One example involves tailoring specific agents based on the cell of origin in aggressive lymphomas. Germinal center (GC)-derived diffuse large B-cell lymphoma (DLBCL) is known to be driven by an addiction to Bcl6...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2013-02-485441

    authors： Amengual JE,Clark-Garvey S,Kalac M,Scotto L,Marchi E,Neylon E,Johannet P,Wei Y,Zain J,O'Connor OA

    更新日期：2013-09-19 00:00:00

  • Isolation and characterization of complement receptor type 1 (CR1) storage vesicles from human neutrophils using antibodies to the cytoplasmic tail of CR1.

    abstract：:Neutrophil (PMN) activation is associated with increased surface expression of several membrane proteins that are translocated from intracellular pools. Indirect evidence suggests that the intracellular storage pools of complement receptor type 1 (CR1) in resting PMN are distinct from traditional granules and may be t...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Kumar A,Wetzler E,Berger M

    更新日期：1997-06-15 00:00:00

  • 2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma.

    abstract：:Cutaneous T-cell lymphomas are disfiguring malignant lymphoproliferative disorders for which standard therapy has been principally palliative. 2-Chlorodeoxyadenosine (2-CdA), a new purine analogue resistant to degradation by adenosine deaminase that has substantial activity against lymphoid neoplasms, was administered...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Saven A,Carrera CJ,Carson DA,Beutler E,Piro LD

    更新日期：1992-08-01 00:00:00

  • DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions.

    abstract：:Age-associated clonal hematopoiesis caused by acquired mutations in myeloid cancer-associated genes is highly prevalent in the normal population. Its etiology, biological impact on hematopoiesis, and oncogenic risk is poorly defined at this time. To gain insight into this phenomenon, we analyzed a cohort of 2530 relat...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2017-04-777029

    authors： Buscarlet M,Provost S,Zada YF,Barhdadi A,Bourgoin V,Lépine G,Mollica L,Szuber N,Dubé MP,Busque L

    更新日期：2017-08-10 00:00:00

  • A homozygous telomerase T-motif variant resulting in markedly reduced repeat addition processivity in siblings with Hoyeraal Hreidarsson syndrome.

    abstract：:Hoyeraal Hreidarsson syndrome (HHS) is a form of dyskeratosis congenita (DC) characterized by bone marrow failure, intrauterine growth retardation, developmental delay, microcephaly, cerebellar hypoplasia, immunodeficiency, and extremely short telomeres. As with DC, mutations in genes encoding factors required for tel...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2012-08-447755

    authors： Gramatges MM,Qi X,Sasa GS,Chen JJ,Bertuch AA

    更新日期：2013-05-02 00:00:00

  • ADAMTS13 turns 3.

    abstract：:It has now been 3 years since the von Willebrand factor (VWF)-cleaving protease implicated in thrombocytopenic purpura (TTP) pathogenesis was identified as ADAMTS13 (a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13). More than 50 ADAMTS13 mutations resulting in familial TTP have been reported...

    journal_title：Blood

    pub_type： 杂志文章,评审

    doi：10.1182/blood-2004-10-4097

    authors： Levy GG,Motto DG,Ginsburg D

    更新日期：2005-07-01 00:00:00

  • The amino-terminal 29- and 72-Kd fragments of fibronectin mediate selective monocyte recruitment.

    abstract：:Proteolytic fragments of fibronectin (Fn) can possess properties not inherent to intact Fn. Previously, only mixtures of low molecular weight Fn fragments, and the 120-Kd fibroblastic cell-binding segment, but not intact Fn, were shown to be selectively chemotactic for human monocytes (MOs). In order to determine if o...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Lohr KM,Kurth CA,Xie DL,Seyer JM,Homandberg GA

    更新日期：1990-11-15 00:00:00

  • U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency.

    abstract：:Small nuclear U1-RNAs (snRNAs), the spliceosome components selectively recognizing donor splice sites (5'ss), were engineered to restore correct mRNA processing in a cellular model of severe coagulation factor VII (FVII) deficiency, caused by the IVS7 9726 + 5g/a change. Three U1-snRNAs, complementary to the mutated 5...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2007-10-117440

    authors： Pinotti M,Rizzotto L,Balestra D,Lewandowska MA,Cavallari N,Marchetti G,Bernardi F,Pagani F

    更新日期：2008-03-01 00:00:00

  • Jun N-terminal kinase promotes proliferation of immature erythroid cells and erythropoietin-dependent cell lines.

    abstract：:Erythropoietin (EPO) is the hormone necessary for development of erythrocytes from immature erythroid cells. EPO activates Jun N-terminal kinase (JNK), a member of the mitogen-activated protein kinase (MAPK) family in the EPO-dependent murine erythroid HCD57 cells. Therefore, we tested if JNK activity supported prolif...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2003-05-1754

    authors： Jacobs-Helber SM,Sawyer ST

    更新日期：2004-08-01 00:00:00

  • An epitope of the transferrin receptor is exposed on the cell surface of high-grade but not low-grade human lymphomas.

    abstract：:In attempting to identify antigens that are differentially expressed on tumor cells following transformation from follicular small cleaved cell lymphoma (FSC) to immunoblastic lymphoma (IL), we identified a unique epitope of the transferrin receptor (TfR). The epitope is available for binding in aggressive lymphomas b...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Esserman L,Takahashi S,Rojas V,Warnke R,Levy R

    更新日期：1989-12-01 00:00:00

  • Requirements of von Willebrand factor to protect factor VIII from inactivation by activated protein C.

    abstract：:The interaction of factor VIII with von Willebrand factor (vWF) was investigated on a quantitative and qualitative level. Binding characteristics were determined using a solid phase binding assay and protection of factor VIII by vWF from inactivation by activated protein C (aPC) was studied using three different assay...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Koppelman SJ,van Hoeij M,Vink T,Lankhof H,Schiphorst ME,Damas C,Vlot AJ,Wise R,Bouma BN,Sixma JJ

    更新日期：1996-03-15 00:00:00

  • Reactive oxygen species rapidly increase endothelial ICAM-1 ability to bind neutrophils without detectable upregulation.

    abstract：:We compared the effects of phorbol 12-myristate 13-acetate (PMA) and thrombin with those of nonlytic concentrations of reactive oxygen species (ROS) generated by hypoxanthine (HX)-xanthine oxidase (XO) on the adhesion properties of human umbilical cord vein endothelial cells (HUVEC) to resting polymorphonuclear neutro...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Sellak H,Franzini E,Hakim J,Pasquier C

    更新日期：1994-05-01 00:00:00

  • Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.

    abstract：:Arsenic trioxide (As2O3) induces clinical remission in acute promyelocytic leukemia (APL) with minimal toxicity and apoptosis in APL-derived NB4 cells at low (1 to 2 micromol/L) concentration. We examined the basis for NB4 cell sensitivity to As2O3 to identify experimental conditions that would render other malignant ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Dai J,Weinberg RS,Waxman S,Jing Y

    更新日期：1999-01-01 00:00:00

  • Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up.

    abstract：:Anti-CD22 moxetumomab pasudotox achieved 46% complete remissions (CRs) in previously reported phase 1 testing in relapsed/refractory hairy cell leukemia (HCL; n = 28). The importance of minimal residual disease (MRD) after CR in HCL is unknown. A 21-patient extension cohort received 50 µg/kg every other day for 3 dose...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2017-09-803072

    authors： Kreitman RJ,Tallman MS,Robak T,Coutre S,Wilson WH,Stetler-Stevenson M,FitzGerald DJ,Santiago L,Gao G,Lanasa MC,Pastan I

    更新日期：2018-05-24 00:00:00

  • Some properties of marrow derived adherent cells in tissue culture.

    abstract：:It has previously been shown that monolayer cultures derived adherent cells (MDAC), apparently consisting of fibroblasts, macrophages, epithelioid cells, and fat cells, can support long-term stem cell proliferation in vitro. In the present study, the hematopoietic support capability of murine MDAC monolayers was confi...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Bentley SA,Foidart JM

    更新日期：1980-12-01 00:00:00

  • GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia.

    abstract：:We designed a trial in which postremission therapy of young patients with de novo acute myeloid leukemia (AML) was decided combining cytogenetics/genetics and postconsolidation levels of minimal residual disease (MRD). After induction and consolidation, favorable-risk patients (FR) were to receive autologous stem cell...

    journal_title：Blood

    pub_type： 临床试验,杂志文章

    doi：10.1182/blood.2018886960

    authors： Venditti A,Piciocchi A,Candoni A,Melillo L,Calafiore V,Cairoli R,de Fabritiis P,Storti G,Salutari P,Lanza F,Martinelli G,Luppi M,Mazza P,Martelli MP,Cuneo A,Albano F,Fabbiano F,Tafuri A,Chierichini A,Tieghi A,Frac

    更新日期：2019-09-19 00:00:00

  • Characterization of human marrow stromal cells: role in progenitor cell binding and granulopoiesis.

    abstract：:Adherent cell layers and their associated extracellular matrices form when human marrow is incubated in cultures containing hydrocortisone and horse serum. These stromal layers contain cells positive for alkaline phosphatase; secrete collagens types I and III and fibronectin, bind the anti-actin monoclonal antibodies ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Liesveld JL,Abboud CN,Duerst RE,Ryan DH,Brennan JK,Lichtman MA

    更新日期：1989-05-15 00:00:00

  • The immunoglobulin heavy-chain locus hs3b and hs4 3' enhancers are dispensable for VDJ assembly and somatic hypermutation.

    abstract：:The more distal enhancers of the immunoglobulin heavy-chain 3' regulatory region, hs3b and hs4, were recently demonstrated as master control elements of germline transcription and class switch recombination to most immunoglobulin constant genes. In addition, they were shown to enhance the accumulation of somatic mutat...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2002-12-3827

    authors： Morvan CL,Pinaud E,Decourt C,Cuvillier A,Cogné M

    更新日期：2003-08-15 00:00:00